drugset / Trial / NCT00225732

Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients

NCT00225732

Phase 3 Completed 319 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery

Timeline

Start
2005-01
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg Intravenous
Comparator Ibuprofen Small molecule 800 mg Intravenous

Indications

No indication recorded.